Literature DB >> 17483299

Functional deficiencies of granulocyte-macrophage colony stimulating factor and interleukin-3 contribute to insulitis and destruction of beta cells.

Thomas Enzler1, Silke Gillessen, Michael Dougan, James P Allison, Donna Neuberg, Darryl A Oble, Martin Mihm, Glenn Dranoff.   

Abstract

The pathogenesis of type 1 diabetes (T1D) involves the immune-mediated destruction of insulin-producing beta cells in the pancreatic islets of Langerhans. Genetic analysis of families with a high incidence of T1D and nonobese diabetic (NOD) mice, a prototypical model of the disorder, uncovered multiple susceptibility loci, although most of the underlying immune defects remain to be delineated. Here we report that aged mice doubly deficient in granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) manifest insulitis, destruction of insulin-producing beta cells, and compromised glucose homeostasis. Macrophages from mutant mice produce increased levels of p40 after LPS stimulation, whereas concurrent ablation of interferon-gamma (IFN-gamma) ameliorates the disease. The administration of antibodies that block cytotoxic T lymphocyte associated antigen-4 (CTLA-4) to young mutant mice precipitates the onset of insulitis and hyperglycemia. These results, together with previous reports of impaired hematopoietic responses to GM-CSF and IL-3 in patients with T1D and in NOD mice, indicate that functional deficiencies of these cytokines contribute to diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483299      PMCID: PMC1924767          DOI: 10.1182/blood-2006-08-043786

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  64 in total

1.  A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse.

Authors:  Bronwyn A O'Brien; Xuan Geng; Catherine H Orteu; Yongqian Huang; Mehran Ghoreishi; YiQun Zhang; Jason A Bush; Gang Li; Diane T Finegood; Jan Peter Dutz
Journal:  J Autoimmun       Date:  2006-01-20       Impact factor: 7.094

2.  On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes.

Authors:  Dunja Bruder; Astrid M Westendorf; Wiebke Hansen; Silvia Prettin; Achim D Gruber; Yingjie Qian; Harald von Boehmer; Karsten Mahnke; Jan Buer
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

3.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

4.  Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.

Authors:  Jian Wang; Taku Yoshida; Fumio Nakaki; Hiroshi Hiai; Taku Okazaki; Tasuku Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-08       Impact factor: 11.205

5.  Modeling CTLA4-linked autoimmunity with RNA interference in mice.

Authors:  Zhibin Chen; John Stockton; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

6.  Nonobese diabetic mouse congenic analysis reveals chromosome 11 locus contributing to diabetes susceptibility, macrophage STAT5 dysfunction, and granulocyte-macrophage colony-stimulating factor overproduction.

Authors:  Sally A Litherland; Kristie M Grebe; Nicole S Belkin; Edward Paek; Jessica Elf; Mark Atkinson; Laurence Morel; Michael J Clare-Salzler; Marcia McDuffie
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

Review 7.  MFG-E8-dependent clearance of apoptotic cells, and autoimmunity caused by its failure.

Authors:  Rikinari Hanayama; Kay Miyasaka; Michio Nakaya; Shigekazu Nagata
Journal:  Curr Dir Autoimmun       Date:  2006

8.  Manipulation of dendritic cells for host defence against intracellular infections.

Authors:  S McCormick; M Santosuosso; X Z Zhang; Z Xing
Journal:  Biochem Soc Trans       Date:  2006-04       Impact factor: 5.407

9.  Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice.

Authors:  I K Campbell; M J Rich; R J Bischof; A R Dunn; D Grail; J A Hamilton
Journal:  J Immunol       Date:  1998-10-01       Impact factor: 5.422

10.  Tissue expression of PD-L1 mediates peripheral T cell tolerance.

Authors:  Mary E Keir; Spencer C Liang; Indira Guleria; Yvette E Latchman; Andi Qipo; Lee A Albacker; Maria Koulmanda; Gordon J Freeman; Mohamed H Sayegh; Arlene H Sharpe
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

View more
  14 in total

1.  Cellular therapies supplement: the role of granulocyte macrophage colony-stimulating factor and dendritic cells in regulatory T-cell homeostasis and expansion.

Authors:  Tao Zou; Atsushi Satake; Priti Ojha; Taku Kambayashi
Journal:  Transfusion       Date:  2011-11       Impact factor: 3.157

2.  The involvement of GM-CSF deficiencies in parallel pathways of pulmonary alveolar proteinosis and the alcoholic lung.

Authors:  William S Slovinsky; Freddy Romero; Dominic Sales; Hoora Shaghaghi; Ross Summer
Journal:  Alcohol       Date:  2018-07-18       Impact factor: 2.405

3.  GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.

Authors:  S M Touhidul Islam; Alan D Curtis; Najla Taslim; Daniel S Wilkinson; Mark D Mannie
Journal:  J Immunol       Date:  2014-07-21       Impact factor: 5.422

4.  DCIR2+ cDC2 DCs and Zbtb32 Restore CD4+ T-Cell Tolerance and Inhibit Diabetes.

Authors:  Jeffrey D Price; Chie Hotta-Iwamura; Yongge Zhao; Nicole M Beauchamp; Kristin V Tarbell
Journal:  Diabetes       Date:  2015-06-12       Impact factor: 9.461

5.  A dual role for the immune response in a mouse model of inflammation-associated lung cancer.

Authors:  Michael Dougan; Danan Li; Donna Neuberg; Martin Mihm; Paul Googe; Kwok-Kin Wong; Glenn Dranoff
Journal:  J Clin Invest       Date:  2011-05-02       Impact factor: 14.808

6.  CD40 activation in human pancreatic islets and ductal cells.

Authors:  D Klein; F Timoneri; H Ichii; C Ricordi; R L Pastori
Journal:  Diabetologia       Date:  2008-07-26       Impact factor: 10.122

7.  Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis.

Authors:  Arthur Mortha; Aleksey Chudnovskiy; Daigo Hashimoto; Milena Bogunovic; Sean P Spencer; Yasmine Belkaid; Miriam Merad
Journal:  Science       Date:  2014-03-13       Impact factor: 47.728

8.  Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.

Authors:  Mark D Mannie; J Lori Blanchfield; S M Touhidul Islam; Derek J Abbott
Journal:  Front Immunol       Date:  2012-08-20       Impact factor: 7.561

9.  Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).

Authors:  Derek J Abbott; J Lori Blanchfield; David A Martinson; Sean C Russell; Najla Taslim; Alan D Curtis; Mark D Mannie
Journal:  BMC Immunol       Date:  2011-12-30       Impact factor: 3.615

Review 10.  Self-antigen presentation by dendritic cells in autoimmunity.

Authors:  Ann-Katrin Hopp; Anne Rupp; Veronika Lukacs-Kornek
Journal:  Front Immunol       Date:  2014-02-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.